Evidence map›Paper›PMID 33638288›Full record

ArticlePsycho-oncology2021

Developing pathways, a hope-enhancing intervention for metastatic lung cancer patients receiving cancer treatment.

Laurie E McLouth, Kaitlyn Weyman, Shannon L Golden, Jennifer S Cheavens, Amy Peterman, Vilma Bursac, Jennifer Gabbard, Kathryn E Weaver

Open access · greenAbstract read
In one paragraph

Article in Psycho-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Goals and goal perceptions in patients with advanced stage lung cancer: a mixed methods study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Laurie E McLouthDepartment of Behavioral Science, Markey Cancer Center, Center for Health Equity Transformation, University of Kentucky College of Medicine, Lexington, Kentucky, USA.ORCID 0000-0002-4888-6520
Kaitlyn WeymanUniversity of Kentucky College of Medicine, Lexington, Kentucky, USA.
Shannon L GoldenDepartment of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Jennifer S CheavensDepartment of Psychology, The Ohio State University, Columbus, Ohio, USA.
Amy PetermanDepartment of Psychological Science, University of North Carolina-Charlotte, Charlotte, North Carolina, USA.
Vilma BursacDepartment of Behavioral Science, Markey Cancer Center, Center for Health Equity Transformation, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Jennifer GabbardDepartment of Internal Medicine, Wake Forest School of Medicine, Section on Gerontology and Geriatric Medicine, Winston-Salem, North Carolina, USA.
Kathryn E WeaverDepartment of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
University of Kentucky · USWake Forest University · USAtrium Health Wake Forest Baptist · USThe Ohio State University · USUniversity of North Carolina at Charlotte · US

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Postdoctoral Training Program in Cancer SurvivorshipR25CA122061 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI AVIS, NANCY E · 2008 to 2018
$3.8M
Piloting Pathways, a Hope-Enhancing Intervention to Address Activity and Role Function in Metastatic Lung Cancer PatientsR03CA235171 · NCI · UNIVERSITY OF KENTUCKY · PI MCLOUTH, LAURIE · 2019 to 2020
$153k
NCATS NIH HHS UL1 TR001420NCATS NIH HHS UL1 TR001998NCI NIH HHS L30 CA231709NCI NIH HHS P30 CA012197NCI NIH HHS P30 CA177558NCI NIH HHS R03 CA235171NCI NIH HHS R25 CA122061
6 · The paper itself

Abstract

objectiveBetween 40% and 65% of lung cancer patients report concern about maintaining valued activities and roles, yet few interventions address this concern. Hope, a patient's perceived ability to generate goals and identify ways to pursue them, may be a promising intervention target to support function among lung cancer patients. The goal of this study was to assess metastatic non-small cell lung cancer (mNSCLC) patient interest and preferences for a hope-enhancing intervention.

methodsWe conducted a sequential mixed-methods (survey followed by semi-structured interviews) study with patients with mNSCLC. Surveys assessed patient interest in, perceived helpfulness of, and preferences for a hope intervention. A subset of 12 patients (and caregivers, when present) completed semi-structured interviews to elicit feedback on proposed intervention content and procedures.

resultsSurvey data from 60 patients (40% male; Mean age = 62.5; SD = 9.3) suggested high perceived importance of pursuing personal goals during cancer treatment, moderate perceived helpfulness in discussing personal goals, and preference for a nurse-led intervention. Based on these data, a 5-session, nurse-led intervention protocol was drafted and reviewed with 12 patients. Interviewed patients and caregivers agreed working towards goals was beneficial, liked the intervention concept, and thought prompts and rating scales on handouts would facilitate discussion. The majority preferred nurse delivery during infusions.

conclusionsA nurse-led hope-enhancing intervention delivered primarily during infusions may be acceptable to mNSCLC patients. Future work should test feasibility and identify ways to incorporate caregivers and oncology providers into hope interventions.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsCaregiversFemaleHumansMaleMedical OncologyMiddle AgedSurveys and Questionnairescancergoal-settinghopelung cancernurse interventiononcologypsycho-oncologystigma

Identifiers

PMID33638288
PMCPMC9009238
OpenAlexW3132112754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.